Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Specify Company / Ticker to Get the Summary
Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Amicus Therapeutics Inc
FOLDCurrent price
8.69 USD
-0.38 USD (-4.19%)
Last closed
9.01 USD
Company
amicusrx.com
ISIN
US03152W1099
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Capitalization
2 958 179 328 USD
Yield for 12 month
-24.70 %
1Y
3Y
5Y
10Y
15Y
FOLD
Amicus Therapeutics, Inc., a biotechnology company, focuses on discovering, developing, and delivering medicines for rare diseases. Its commercial product and product candidates include Galafold, an oral precision medicine for the treatment of adults with a confirmed diagnosis of Fabry disease and an amenable galactosidase alpha gene variant; and Pombiliti + Opfolda, for the treatment of late onset. It has collaboration and license agreements with the University of Pennsylvania to research and develop parvovirus gene therapy products; and GlaxoSmithKline. Amicus Therapeutics, Inc. was incorporated in 2002 and is headquartered in Princeton, New Jersey. Address: 47 Hulfish Street, Princeton, NJ, United States, 08542
Check your investment idea
Find the best to beat the market
TSLA
Tesla Motors
AAPL
Apple
MSFT
Microsoft
Analytics
WallStreet Target Price
17.33 USDP/E ratio
–Dividend Yield
–Current Year
+399 356 000 USD
Last Year
+329 233 000 USD
Current Quarter
+141 517 000 USD
Last Quarter
+126 669 000 USD
Current Year
+362 030 000 USD
Last Year
+290 634 000 USD
Current Quarter
+128 238 000 USD
Last Quarter
+113 226 000 USD
Key Figures FOLD
1 year
3 years
5 years
10 years
EBITDA
23 089 000 USD
Operating Margin TTM
Price to Earnings
–
Return On Assets TTM
1.16 %
PEG Ratio
-0.18
Return On Equity TTM
-67.09 %
Wall Street Target Price
17.33 USD
Revenue TTM
493 671 008 USD
Book Value
0.60 USD
Revenue Per Share TTM
Dividend Share
–
Quarterly Revenue Growth YOY
36.70 %
Dividend Yield
–
Gross Profit TTM
290 634 000 USD
Earnings per share
-0.34 USD
Diluted Eps TTM
-0.34 USD
Most Recent Quarter
III 2024
Quarterly Earnings Growth YOY
–
Profit Margin
-21.21 %
Dividend Analytics FOLD
Max Ratio
>10 - expected double digit dividend yield on cost over 10Y >5 - expected 5-9 dividend yield on cost over 10Y <5 - expected <5 dividend yield on cost over 10Y MaxRatio is an estimated 10Y dividend yield on cost calculated by combining the current dividend yield with the 5-year & 10-year average dividend growth rate, projected over the next 10 years discounted based on current Financial Score. It provides a projected outlook on future dividend returns.
–5Y Dividend Growth
–Consecutive Years
–5Y Average Payout Ratio
–Dividend History FOLD
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Ex Dividend Date
–
Dividend CAGR 3Y
–
Dividend CAGR 5Y
–
Dividend CAGR 10Y
–
Consecutive Years
Consistent Years
Continuous Dividends
Forward Annual Dividend Yield
–
Forward Annual Dividend
– USD
Last Split Factor
–
Payout Ratio
–
Last Split Date
–
Stock Valuation FOLD
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
–
Forward PE
31.45
Enterprise Value Revenue
6.06
Price Sales TTM
5.99
Enterprise Value EBITDA
-35.99
Price Book MRQ
15.64
Financials FOLD
1 year
3 years
5 years
10 years
15 years
| Results | 2019 | Dynamics |
* The data for this period has not yet been published
Technical indicators FOLD
For 52 weeks
9.02 USD
14.57 USD
50 Day MA
10.53 USD
Shares Short Prior Month
20 997 095
200 Day MA
10.72 USD
Short Ratio
8.83
Shares Short
20 825 763
Short Percent
7.01 %
BeatStart